Ï㽶ÊÓƵ

Home

Daniel Gendron, MD

Daniel Gendron, MD
Contact Information
Phone: 
514-398-8551
Link(s): 
Stories Daniel Gendron
Rare Neurological Diseases Research Group
Biography: 

Dr. Daniel Gendron and his co-workers provide excellent back-up for clinical diagnosis in the Institute. Dr. Gendron is also active in experimental trials of pyridostigmin treatment protocols for the post-polio syndrome.

Selected publications: 

Trojan DA, Gendron D, Cashman NR. Stimulation frequency-dependent neuromuscular junction transmission defects in patients with prior poliomyelitis. J Neurol Sci. 1993 Sep;118(2):150-7.

Trojan DA, Gendron D, Cashman NR. Anticholinesterase-responsive neuromuscular junction transmission defects in post-poliomyelitis fatigue. J Neurol Sci. 1993 Feb;114(2):170-7.

Trojan DA, Gendron D, Cashman NR. Electrophysiology and electrodiagnosis of the post-polio motor unit. Orthopedics. 1991 Dec;14(12):1353-61. Review.

Teitelbaum JS, Zatorre RJ, Carpenter S, Gendron D, Evans AC, Gjedde A, Cashman NR. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N Engl J Med. 1990 Jun 21;322(25):1781-7.

So N, Berkovic S, Andermann F, Kuzniecky R, Gendron D, Quesney LF. Myoclonus epilepsy and ragged-red fibres (MERRF). 2. Electrophysiological studies and comparison with other progressive myoclonus epilepsies. Brain. 1989 Oct;112 ( Pt 5):1261-76.

Research areas: 
Rare Neurological Diseases

The Neuro logoÌýMcGill logo

Ìý

The Neuro (Montreal Neurological Institute-Hospital)Ìýis a bilingual academic healthcare institution. We are aÌýMcGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the Ï㽶ÊÓƵ Health Centre.ÌýWe areÌýproud to be a Killam Institution, supported by the Killam Trusts.

Ìý

Ìý

Back to top